FDA accepts Organogenesis BLA for knee osteoarthritis treatment ReNu

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. IBM
10. KNX

Go back to FDA accepts Organogenesis BLA for knee osteoarthritis treatment ReNu
(NASDAQ: ORGO) Delayed: 2.43 -0.04 (1.62%)
Previous Close $2.47    52 Week High $ 
Open $2.45    52 Week Low $ 
Day High $2.48    P/E N/A 
Day Low $2.35    EPS $ 
Volume 782,995